Free Trial

Medtronic (MDT) 10K Form and Latest SEC Filings 2026

Medtronic logo
$77.99 +0.39 (+0.50%)
Closing price 03:59 PM Eastern
Extended Trading
$77.85 -0.14 (-0.18%)
As of 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Medtronic SEC Filings & Recent Activity

Medtronic (NYSE:MDT) has submitted 622+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Medtronic's financial statements. The most recent filing was a Form SCHEDULE 13G submitted on May 6, 2026.

Form 4
Medtronic plc Reports Ownership Change on May. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Medtronic Files Current Report on Mar. 24, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Medtronic Files Quarterly Report on Aug. 26, 2025

The 10-Q contains Medtronic's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Medtronic SEC Filing History

Browse Medtronic's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/06/2026 7:11 PM
Medtronic (1613103) Filed by
MiniMed Group, Inc. (2062583) Subject
Form SCHEDULE 13G
05/04/2026 4:12 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:15 PM
Jellison William R (1189883) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:15 PM
Lee Joon Sup (2075730) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:16 PM
Lewis Gregory P (1748656) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:16 PM
Lofton Kevin E (1468818) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:17 PM
Medtronic (1613103) Issuer
NABEL ELIZABETH G (1619929) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:18 PM
Medtronic (1613103) Issuer
Powell Kendall J (1298823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:18 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2026 11:26 AM
Medtronic (1613103) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
03/27/2026 9:30 AM
Medtronic (1613103) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/24/2026 3:42 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2026 3:15 PM
Medtronic Global Holdings S.C.A. (1647572) Filer
MEDTRONIC INC (64670) Filer
Medtronic (1613103) Filer
Form S-3ASR
03/05/2026 7:39 PM
Medtronic (1613103) Reporting
MiniMed Group, Inc. (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/05/2026 4:22 PM
Medtronic (1613103) Issuer
Pieton Thierry (2056622) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:48 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 2:19 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 5:48 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2026 3:06 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2026 4:06 PM
Anteris Technologies Global Corp. (2011514) Subject
Medtronic (1613103) Filed by
Form SCHEDULE 13D
12/17/2025 3:17 PM
Martha Geoffrey (1560409) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 3:18 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 3:18 PM
Medtronic (1613103) Issuer
Wall Brett A. (1473812) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 3:11 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 10:20 AM
Medtronic (1613103) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
11/24/2025 3:17 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 3:13 PM
Medtronic (1613103) Issuer
Smith Gregory L (1533098) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 10:05 AM
Medtronic (1613103) Subject
Smith Gregory L (1533098) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 5:47 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2025 4:21 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 3:21 PM
Medtronic (1613103) Filer
Form 11-K/A
10/24/2025 3:21 PM
Medtronic (1613103) Filer
Form 11-K/A
10/21/2025 3:16 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2025 8:44 AM
Medtronic (1613103) Subject
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Form 25-NSE
09/29/2025 9:44 AM
Medtronic (1613103) Subject
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Form 25-NSE
09/29/2025 8:53 AM
Medtronic (1613103) Filer
Form CERT
09/29/2025 8:09 AM
Medtronic Global Holdings S.C.A. (1647572) Filer
MEDTRONIC INC (64670) Filer
Medtronic (1613103) Filer
Form 8-A12B
09/29/2025 7:45 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2025 3:41 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2025 3:19 PM
Medtronic Global Holdings S.C.A. (1647572) Filer
MEDTRONIC INC (64670) Filer
Medtronic (1613103) Filer
Form 424B5
09/15/2025 3:24 PM
Medtronic (1613103) Subject
Form FWP
09/15/2025 5:03 AM
Medtronic Global Holdings S.C.A. (1647572) Filer
MEDTRONIC INC (64670) Filer
Medtronic (1613103) Filer
Form 424B3
09/05/2025 3:18 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 2:23 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025 4:26 PM
Medtronic (1613103) Filer
Form IRANNOTICE
08/26/2025 4:26 PM
Medtronic (1613103) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/25/2025 4:18 PM
Jellison William R (1189883) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 3:33 PM
Medtronic (1613103) Filer
Form DEFA14A
08/25/2025 3:24 PM
Medtronic (1613103) Filer
Form DEF 14A
08/21/2025 3:22 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025 5:49 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025 4:25 PM
Medtronic (1613103) Filer
Form PRE 14A
08/01/2025 12:10 PM
Medtronic (1613103) Issuer
Smith Gregory L (1533098) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025 3:30 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025 9:33 AM
Medtronic (1613103) Issuer
Quinn Michelle (1964281) Reporting
Form 3
Initial statement of beneficial ownership of securities  
07/02/2025 12:17 PM
Medtronic (1613103) Subject
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Form 25-NSE
06/23/2025 3:17 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025 5:46 AM
Medtronic (1613103) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/20/2025 5:46 AM
Medtronic (1613103) Filer
Form IRANNOTICE
06/06/2025 1:43 PM
Medtronic (1613103) Subject
Salmon Sean (1792380) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025 3:29 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 3
Initial statement of beneficial ownership of securities  
06/04/2025 3:30 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025 4:30 PM
Medtronic (1613103) Filer
Form SD
Specialized Disclosure Report  
05/21/2025 5:47 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Medtronic SEC Filings - Frequently Asked Questions

Medtronic (MDT) has submitted 622+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Medtronic's fiscal year ends on April 30. The company typically files its 10-K annual report by the end of June, covering the prior fiscal year's financial results. Key financial data from these reports is available on Medtronic's financial statements page.

The most recent filing was a Form SCHEDULE 13G submitted on May 6, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:MDT) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners